Label each vial with the reconstitution date and discard after 28 days regardless of remaining volume
Q5 - How does glutathione affect aging
Medical Considerations Low IGF-1 with symptoms of GH deficiency may warrant: GH stimulation testing Consideration of GH or peptide therapy under endocrinology or functional medicine guidance High IGF-1 may require: Acromegaly screening (IGF-1 + oral glucose tolerance GH suppression test) Adjustment of therapy dosages Cancer risk assessment and monitoring IGF-1, Longevity, and Health Span The relationship between IGF-1 and lifespan is U-shaped both extremes are associated with higher risk
The beyond-use date for this compounded medication is determined by the compounding pharmacy based on stability data and compounding standards
Sicca syndrome [3] [4] Ocular symptoms Xerophthalmia: dry eyes due to decreased secretion of tears (daily, persistent) Keratoconjunctivitis sicca Conjunctival injection Eye itching or burning sensation Blurred vision Recurrent sensation of sand or a foreign body in the eyes Oral symptoms Xerostomia: dry mouth due to decreased secretion of saliva (daily, persistent) which may lead to: Dental caries and oral infections Parotid gland enlargement, often bilateral Tongue fissures Frequent need to drink liquids to aid swallowing and/or speaking Other glandular symptoms Vaginal dryness, leading to dyspareunia and an increased risk of infections Nasal dryness, leading to chronic rhinitis and epistaxis Pharyngeal, tracheal, and bronchial dryness, causing persistent dry cough Xerosis: abnormal skin dryness and pruritus (secondary to hypohidrosis or anhidrosis) Xerostomia and xerophthalmia are the classic symptoms of sicca syndrome and are present in 95% of patients with Sjogren syndrome
This means that the medication may no longer provide the therapeutic benefits required, rendering your treatment less effective or even useless
